Multiplex Assay Market to Reach $7.7 Billion, Globally, by 2032 at 7.8% CAGR: Allied Market Research
Increase in the adoption of multiplex assay products, numerous advances in multiplex assays over traditional assays, and the increase in acceptance of personalized treatment in developing countries ...
LISBON, Portugal--(BUSINESS WIRE)--At the 32 nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its ...
Multiplex qPCR is a popular area of interest for many assay developers. Thanks to distinct reporter dyes, multiple reactions can be combined into a single well, with each target detected independently ...
Assay developers in biopharma and research labs strive to save time, reduce costs, and ensure accurate and reproducible results. In quantitative PCR (qPCR) assays, multiplexing—the simultaneous ...
Novel Immunoassay Platform for Evaluating Multiple Analytes with Minimal Sample Volume The quantitative analysis of cytokines and other analytes in plasma, serum, or cell lysate is becoming ...
Background PSA-directed prostate cancer screening leads to a high rate of false positive identifications and an unnecessary biopsy burden. Epigenetic biomarkers have proven useful, exhibiting frequent ...
The immunoassay—a mainstay of life sciences and clinical diagnostic laboratories—detects and quantifies proteins and other kinds of molecules in complex samples, usually through the use of antibodies.
SANTA CLARA, Calif, & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company® ...
QuantiPath, a molecular diagnostics company advancing pathogen detection and food safety innovation, today announced a ...
Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...
EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex ® CTDplus multiplex assay. The multiplex assay enables a syndromic approach, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results